S-1 (Cervical Cancer) – Analysis and Forecasts to 2020

Published: October 2011
No. of Pages: 23
Price: $ 2000


GlobalData’s pharmaceuticals report, “ S-1 ( Cervical Cancer) - Analysis and Forecasts to 2020” provides S-1 sales forecasts for Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2015-2020). The report also includes information on Cervical Cancer market. This report is built using data and information sourced from GlobalData’s proprietary databases, primary and secondary research using Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.

Browse All: Pharmaceuticals Market Research Reports

Scope
- Therapy area profile including patient population for the US, EU5 and Japan (seven major markets)
- Analysis and review of S-1 including sales data
- Qualitative and quantitative assessment of market space
- Analysis of the trends, drivers and restraints shaping and defining the markets
- In-depth analysis of S-1 including efficacy, safety, pricing, competition and other details which influence its sales potential
- Detailed sales forecasts for 2015-2020 for S-1 in Japan

Reasons to buy
- Understand and capitalize by identifying products that are most likely to ensure a robust return
- Stay ahead of competition by understanding the changing competitive landscape
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
- Make more informed business decisions from insightful and in-depth analysis of the drug’s performance
- Examine the historical sales performance of a drug in seven major markets
- Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets

Russia Uranium Mining Market Overview and Forecast to 2020: Trends, Fiscal Regime, Major Projects, and Competitive Landscape

Published: October 2011
No. of Pages: 30
Price: $ 1500


GlobalData’s mining industry offering, 'Russia Uranium Mining Market Overview and Forecast to 2020: Trends, Fiscal Regime, Major Projects, and Competitive Landscape' provides a comprehensive understanding of the Uranium mining industry in Russia. This report provides historical and forecasted data on Uranium production to 2020. In additions to this, the reports also includes drivers and restraints affecting the industry, profiles of major Uranium mining companies, information on major active and planned mines and regulations governing the industry. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope
- Overview of the Russia Uranium mining industry, with detailed information about production and reserves
- Historic data from 2000 to 2010, and forecast to 2020
- Key growth factors and restraints affecting the Russia Uranium mining industry
- List of major active and planned Uranium mines
- Policy and regulatory framework governing the Uranium mining industry
- Profiles of key Uranium mining companies

Reasons to buy
- Gain a strong understanding of the country’s uranium mining industry
- Facilitate market analysis and forecasting of future industry trends
- Facilitate decision making and strategy formulation on the basis of strong historic and forecast production, consumption and trade data.
- Identify key growth and investment opportunities in the country's uranium mining industry
- Position yourself to gain the maximum advantage of the industry’s growth potential

North and South America Renewable Energy Policy Handbook 2011

Published: October 2011
Price: $ 3500


North and South America Renewable Energy Policy Handbook 2011” is the latest policy report from GlobalData, the industry analysis specialists that offer comprehensive information on major policies governing renewable energy market in the region. The report presents an in-depth analysis of the renewable energy policies across the major countries in North and South America namely the US, Canada, Mexico, Brazil and Argentina. It details the key policy instruments adopted by the US Federal and State governments that led to huge development in the renewable industry. The report also provides insights to major policy initiatives taken up by the US Administration for the market development of renewable energy sources such as wind, solar, geothermal, biopower and biofuels. For Canada, in addition to the federal policies, the report details the policies of the provinces that are leading the renewable energy industry in the country. For other major countries, it provides the current and future renewable energy targets and plans along with the present policy framework, giving a fair idea of overall growth potential of their renewable energy industry. The report also provides major technology specific policies and incentives provided in each of these countries. The report is built using data and information sourced from industry associations, government websites and statutory bodies. The information is also sourced through other secondary research sources such as industry and trade magazines.

Scope
• The report covers policy measures and incentives used by the major countries in North and South America to promote renewable energy.
• The report details promotional measures in different countries both for the overall renewable energy industry and for specific renewable energy technologies namely solar, wind, geothermal, hydro and bioenergy.
• The report also highlights the differences and focus of the renewable energy policy frameworks in different countries in North and South America.
• The report provides a platform for comparison of various 2011 North and South America Renewable Energy Policy.

Reasons to Buy
• The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
• Develop business strategies with the help of specific insights about policy decisions being taken on renewable energy by different markets.
• Identify opportunities and challenges in exploiting the renewable energy market.
• Compare the level of support provided to different renewable energy technologies in different countries.
• Increase future revenue and profitability with the help of insights on the future opportunities and critical success factors in the renewable energy market.
• Be ahead of competition by keeping yourself abreast of all the latest policy changes.

Gastroesophageal Reflux Disease (GERD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Published: October 2011
No. of Pages: 71
Price: $ 3500

GlobalData, the industry analysis specialist, has released its new report, “Gastroesophageal Reflux Disease (GERD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global Gastroesophageal Reflux Disease (GERD) Therapeutics market. The report identifies the key trends shaping and driving the global Gastroesophageal Reflux Disease (GERD) Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Gastroesophageal Reflux Disease (GERD) Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Browse All: Pharmaceuticals Market Research Reports

Scope

The report provides information on the key drivers and challenges of the Gastroesophageal Reflux Disease (GERD) Therapeutics market. Its scope includes - 

- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Gastroesophageal Reflux Disease (GERD) Therapeutics market revenues data from 2005 to 2010, forecast for eight years to 2018. 

- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.

- Analysis of the current and future competition in the seven key countries Gastroesophageal Reflux Disease (GERD) Therapeutics market. 

- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. 

- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Gastroesophageal Reflux Disease (GERD) Therapeutics market.

- Analysis of key recent licensing and partnership agreements in Gastroesophageal Reflux Disease (GERD) Therapeutics market

Reasons to buy

The report will enhance your decision making capability. It will allow you to - 

- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. 

- Develop business strategies by understanding the trends shaping and driving the global Gastroesophageal Reflux Disease (GERD) Therapeutics market. 

- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Gastroesophageal Reflux Disease (GERD) Therapeutics market in future. 

- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. 

- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. 

- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. 

- What’s the next big thing in the global Gastroesophageal Reflux Disease (GERD) Therapeutics market landscape? – Identify, understand and capitalize.

Glioblastoma Multiforme (GBM) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Published: September 2011
No. of Pages: 88
Price: $ 3500


GlobalData, the industry analysis specialist, has released its new report, “Glioblastoma Multiforme (GBM) Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global GBM market. The report identifies the key trends shaping and driving the global GBM market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global GBM sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

GlobalData estimates that the global GBM therapeutics market was valued at $370m in 2010, and is forecast to grow at a compound annual growth rate (CAGR) of 2.4% to reach $449m by 2018. This low growth rate is primarily attributed to the patent expiry of Temodal/Temodar (temozolomide, TMZ) in Europe in 2009 and in the US in 2014. The entry of low cost generics in Europe in 2010 has led to a decrease in the market valuation. TMZ has been an established standard of care for newly diagnosed GBM patients since its approval in 2005 and has led to a considerable increase in the number of patients on chemotherapy. In addition, the late stage pipeline products including Avastin (bevacizumab), enzastaurin and cilengitide for GBM are not expected to significantly drive the market upon their launch as the clinical trial results have not shown a significant increase in survival rate.


Browse All: Pharmaceuticals Market Research

Scope
The report provides information on the key drivers and challenges of the GBM market. Its scope includes -
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) GBM market revenues data from 2005 to 2010, forecast for eight years to 2018.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Pipeline candidates fall under major therapeutic classes such as angiogenic inhibitors, VEGF inhibitors, tyrosine kinase inhibitors, gene therapy, anti-mitotic agents, stem cell therapy.
- Analysis of the current and future competition in the global GBM market. Key market players covered are Hoffmann-La Roche Ltd, Merck, Eli Lilly, Ark Therapeutics and Antisense Pharma.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the GBM therapeutics market.
- Analysis of key recent licensing and partnership agreements in GBM market.

Reasons to buy
The report will enhance your decision making capability. It will allow you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global GBM market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global GBM market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global GBM market landscape? – Identify, understand and capitalize.

Nigeria Oil Markets, 2011

Published: October2011
No. of Pages: 119
Price: $ 2500


This profile is the essential source for top-level energy industry data and information. The report Nigeria Oil Market provides an overview of each of the key sub-segments of the energy industry in Nigeria. It details the market structure, regulatory environment, infrastructure and provides historical and forecasted statistics relating to the supply/demand balance for each of the key sub-segments. It also provides information relating to the crude oil assets (oil fields, refineries, pipelines and storage terminals) in Nigeria. The report compares the investment environment in Nigeria with other countries in the region. The profiles of the major companies operating in the crude oil sector in Nigeria together with the latest news and deals are also included in the report.

Scope
- Historic and forecast data relating to production, consumption, imports, exports and reserves are provided for each industry sub-segment for the period 2000-2020.
- Historical and forecast data and information for all the major oil fields, refineries, pipelines and storage terminals in Nigeria for the period 2000-2015.
- Operator and equity details for major crude oil assets in Nigeria.
- Key information relating to market regulations, key energy assets and the key companies operating in the Nigeria’s energy industry.
- Information on the top companies in the Nigeria including business description, strategic analysis, and financial information.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity and venture capital investments, and IPOs.

Reasons to buy
- Gain a strong understanding of the country’s energy market.
- Facilitate market analysis and forecasting of future industry trends.
- Facilitate decision making on the basis of strong historic and forecast production, reserves and capacity data.
- Assess your competitor’s major crude oil assets and their performance.
- Analyze the latest news and financial deals in the oil sector of each country.
- Develop strategies based on the latest operational, financial, and regulatory events.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market.
- Identify and analyze the strengths and weaknesses of the leading companies in the country.

Benzene Global Market to 2020 - Driven by the Styrene Monomer Market, Asian Consumption Will Continue to Dominate

Published: October2011
Price: $ 3500


GBI Research' s report, "Benzene Global Market to 2020 - Driven by the Styrene Monomer Market, Asian Consumption Will Continue to Dominate" provides in-depth analysis of the global benzene market with demand and production forecasts up to 2020. The historical and forecast statistics of the market are provided for all the major regions and major countries of the world. The factors that drive and restrain the growth of the benzene market are also analyzed in the report. The research also presents end use trend analysis and forecast of benzene for all the major regions and countries. He research includes analysis and forecast on benzene price and international trade for all the major countries. In addition, the research also provides capacity share analysis of the leading benzene producers for all the major regions and countries of the world.

Browse All: Chemicals Market

Scope
• Benzene market by volume globally and for key regions and countries from 2000 to 2010 and forecasts for ten years to 2020.
• Detailed demand analysis of benzene by end use applications at global level and for all the major regions and countries.
• Price analysis and forecast for benzene in all the major countries of the world.
• International trade analysis and forecast for benzene in all the major countries of the world.
• Detailed analysis of the key drivers and restraints for the benzene market in all the major regions.
• Information on the competitive landscape with the capacity shares of the leading companies in the major regions and countries of the world.

Reasons to Buy
• Obtain the most up to date information available on the benzene industry globally.
• Identify opportunities and challenges in the global benzene market to 2020.
• Identify the macro and micro-economic trends shaping and driving the benzene markets in various regions.
• Develop invest-divest strategies through knowledge of the global, regional and key country market sizes, growth trends and competitive landscapes.
• Make more informed business decisions from the insightful and in-depth analysis of the market landscape and the factors shaping it.
• Increase future revenue and profitability with the help of insights on the future opportunities and critical success factors in the global benzene markets.

Spinal Surgery Devices Market - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Published: October 2011
Price: $ 3500


GBI Research’s report, “Spinal Surgery Devices Market - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global aesthetic Devices market. The report provides market landscape, competitive landscape and market trends information on two spinal surgery devices market categories – spinal fusion devices and spinal non-fusion devices. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape with major acquisitions and mergers in the last three years and a detailed analysis of the pipeline products in each category. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Browse All: Medical Devices Market Research

Scope
• The report analyses the Spinal Surgery Devices Market along with the major forces driving the current market and the potential challenges that can restrain the growth. The scope of the report includes:
• Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
• Market size data for two spinal surgery devices market categories – spinal fusion devices and spinal non-fusion devices
• Annualized market revenues data, forecast forward for 7 years to 2017. Company share data for 2010.
• Qualitative analysis of key market trends for global spinal surgery devices market.
• Qualitative analysis of market drivers and restraints by each category within the spinal surgery devices market.
• The report also covers information on the leading market players, the competitive landscape, and the leading technologies.

Reasons to Buy
The report will enhance your decision making capability. It will allow you to
• Develop business strategies by understanding the trends and developments that are driving the spinal surgery devices market globally.
• Design and develop your product development, marketing and sales strategies.
• Exploit M&A opportunities by identifying market players with the most innovative pipeline.
• Develop market-entry and market expansion strategies.
• Identify key players best positioned to take advantage of the emerging market opportunities.
• Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
• What’s the next being thing in the spinal surgery devices market landscape? – Identify, understand and capitalize.
• Make more informed business decisions from the insightful and in-depth analysis of the global spinal surgery devices market and the factors shaping it.

Ophthalmic Diagnostic Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Published: October2011
Price: $ 3500


GlobalData’s new report, “Ophthalmic Diagnostic Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global ophthalmic diagnostic equipment market. The report provides market landscape, competitive landscape and market trends as well as comprehensive information on the key trends affecting the market, and key analytical content on the market’s dynamics. The report also reviews the competitive landscape and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Browse All: Medical Devices Market

Scope
• Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
• Key segments covered include Optical Coherence Tomography (OCT), Retinal Ultrasound Imaging Systems, Corneal Topography (CT) Systems, Perimeters, Ophthalmoscopes, Refractors, Slit Lamps, Tonometers and Fundus Cameras.
• Annualized market revenues data from 2003 to 2010, forecast forward for seven years to 2017. Company shares data for 2010.
• Qualitative analysis of key market trends, market drivers, and restraints within the ophthalmic diagnostic equipment market.
• The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
• Key players covered include TOPCON CORPORATION, Carl Zeiss, Haag-Streit, Heine Optotechnik and NIDEK.

Reasons to Buy
• Develop business strategies by understanding the trends and developments that are driving the ophthalmic diagnostic equipment market globally.
• Design and develop your product development, marketing and sales strategies.
• Develop market-entry and market expansion strategies.
• Identify key players best positioned to take advantage of the emerging market opportunities.
• Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
• What is the next big thing in the ophthalmic diagnostic equipment market landscape? Identify, understand and capitalize.
• Make more informed business decisions from the insightful and in-depth analysis of the global ophthalmic diagnostic equipment market and the factors shaping it.

Bare Metal Stents (BMS) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Published: October2011
Price: $ 3500


GlobalData’s new report, “Bare Metal Stents (BMS) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global bare metal stents market. The report provides market landscape, competitive landscape and market trends information on the bare metal stents market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Browse All: Medical Devices Market Research

Scope
• Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
• Annualized market revenues data from 2003 to 2010, forecast forward for seven years to 2017. Company shares data for 2010.
• Qualitative analysis of key market trends, market drivers, and restraints by each category within the bare metal stents market.
• The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
• Key players covered include Abbott Laboratories, Boston Scientific Corporation and Medtronic.

Reasons to Buy
• Develop business strategies by understanding the trends and developments that are driving the bare metal stents market globally.
• Design and develop your product development, marketing and sales strategies.
• Develop market-entry and market expansion strategies.
• Identify key players best positioned to take advantage of the emerging market opportunities.
• Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
• What’s the next big thing in the bare metal stents market landscape? – Identify, understand and capitalize.
• Make more informed business decisions from the insightful and in-depth analysis of the global bare metal stents market and the factors shaping it.

Cataract Surgery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Published: October2011
Price: $ 3500


GlobalData’s new report, “Cataract Surgery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global cataract surgery devices market. The report provides market landscape, competitive landscape and market trends information on the cataract surgery devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market’s dynamics. The report also reviews the competitive landscape and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Browse All: Medical Devices Market

Scope
• Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
• Key segments covered include Intra Ocular Lens (IOL), Ophthalmic Viscoelastic Devices (OVD) and Phacoemulsification Equipment.
• Annualized market revenues data from 2003 to 2010, forecast forward for seven years to 2017. Company shares data for 2010.
• Qualitative analysis of key market trends, market drivers, and restraints within the cataract surgery devices market.
• The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
• Key players covered include Alcon, Inc., Abbott Medical Optics, Inc., Bausch & Lomb Incorporated and HOYA Corporation.

Reasons to Buy
• Develop business strategies by understanding the trends and developments that are driving the cataract surgery devices market globally.
• Design and develop your product development, marketing and sales strategies.
• Develop market-entry and market expansion strategies.
• Identify key players best positioned to take advantage of the emerging market opportunities.
• Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
• What’s the next big thing in the cataract surgery devices market landscape? – Identify, understand and capitalize.
• Make more informed business decisions from the insightful and in-depth analysis of the global cataract surgery devices market and the factors shaping it.

Ukraine Iron Ore Mining Market Overview and Forecast to 2020: Trends, Fiscal Regime, Major Projects, and Competitive Landscape

Published: October2011
No. of Pages: 44
Price: $ 1500

Ukraine Iron Ore Mining Market Overview and Forecast to 2020: Trends, Fiscal Regime, Major Projects, and Competitive Landscape ""Ukraine Iron Ore Mining Market Overview and Forecast to 2020: Trends, Fiscal Regime, Major Projects, and Competitive Landscape" provides a comprehensive understanding of the Iron ore mining industry in Ukraine. This report provides historical and forecasted data on Iron ore production, consumption and trade (export and/or imports) to 2020. In additions to this, the reports also includes drivers and restraints affecting the industry, profiles of major Iron ore mining companies, information on major active and planned mines and regulations governing the industry. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by our team of industry experts.

Browse All: Mining Market Research Reports

Scope

• Overview of the Ukraine Iron ore mining industry, with detailed information about production, production by forms, reserves, consumption, consumption and trade

• Historic data from 2000 to 2010, and forecast to 2020

• Key growth factors and restraints affecting the Ukraine Iron ore mining industry

• List of major active and planned Iron ore mines

• Policy and regulatory framework governing the Iron ore mining industry

• Profiles of key Iron ore mining companies

Reasons to buy

• Gain a strong understanding of the country's Iron ore mining industry

• Facilitate market analysis and forecasting of future industry trends

• Facilitate decision making and strategy formulation on the basis of strong historic and forecast production, consumption and trade data.

• Identify key growth and investment opportunities in the country's Iron ore mining industry

• Position yourself to gain the maximum advantage of the industry's growth potential

Psoriasis Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Published: October 2011
No. of Pages: 102
Price: $ 3500

GlobalData, the industry analysis specialist, has released its new report, “Psoriasis Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global Psoriasis Therapeutics market. The report identifies the key trends shaping and driving the global Psoriasis Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Psoriasis Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Browse All: Pharmaceuticals Market Research Reports

Scope

The report provides information on the key drivers and challenges of the Psoriasis Therapeutics market. Its scope includes - 

- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Psoriasis Therapeutics market revenues data from 2005 to 2010, forecast for eight years to 2018. 

- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.

- Analysis of the current and future competition in the seven key countries Psoriasis Therapeutics market. 

- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. 

- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Psoriasis Therapeutics market.

- Analysis of key recent licensing and partnership agreements in Psoriasis Therapeutics market

Reasons to buy

The report will enhance your decision making capability. It will allow you to - 

- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. 

- Develop business strategies by understanding the trends shaping and driving the global Psoriasis Therapeutics market. 

- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Psoriasis Therapeutics market in future. 

- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. 

- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. 

- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. 

- What’s the next big thing in the global Psoriasis Therapeutics market landscape? – Identify, understand and capitalize.

http://www.reportsnreports.com/Purchase.aspx?name=131735

South and Central America Ophthalmic Devices Market Outlook to 2017

Published: October 2011
No. of Pages: 125
Price: $ 3500


GlobalData’s new report, “South and Central America Ophthalmic Devices Market Outlook to 2017” provides key market data on the South and Central America Ophthalmic Devices market – Argentina, Brazil and Mexico. The report provides value (USD million) data for all the market categories – Cataract Surgery Devices, Glaucoma Surgery Devices, Ophthalmic Diagnostic Equipment, Refractive Surgery Devices, Vision Care and Vitreo Retinal Surgery Devices. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.


Browse All: Medical Devices Market Research Reports

Scope
- Countries covered include Argentina, Brazil and Mexico.
- Market size and company share data for Ophthalmic Devices market categories – Cataract Surgery Devices, Glaucoma Surgery Devices, Ophthalmic Diagnostic Equipment, Refractive Surgery Devices, Vision Care and Vitreo Retinal Surgery Devices.
- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the market categories and countries.
- Global corporate-level profiles of key companies operating within the South and Central America Ophthalmic Devices market..
- Key players covered include Essilor International, CIBA Vision Corporation, Johnson & Johnson Vision Care, Inc., Solotica Lentes de Contato, Alcon, Inc., Bausch & Lomb Incorporated and others.

Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the South and Central America Ophthalmic Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Hydropower (Large Hydro, Small Hydro and Pumped Storage) - Global Market Size, Competitive Landscape, Regulations and Investment Analysis to 2020

Published: October 2011
No. of Pages: 152
Price: $ 3500

Hydropower (Large Hydro, Small Hydro and Pumped Storage) - Global Market Size, Competitive Landscape, Regulations and Investment Analysis to 2020 is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the hydropower industry. The research provides an understanding of the hydropower market by project type, that is, large-scale hydro, small-scale hydro and pumped storage. The research also provides historical and forecast analysis of the global hydropower installed capacity, power generation and market value. The report details about investment scenario, hydro turbine market analysis as well as key drivers and challenges in the global hydropower industry. The report provides the competitive landscape of major hydropower project owners in the countries such as the US, Canada, Brazil, Russian Federation, Norway, China, Japan and India. The hydropower report also provides insights about some of the emerging hydropower markets such as, Venezuela, Turkey, Switzerland and Mexico. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s Team of industry experts.

Scope

The scope of the report includes:

• Data on the Installed Capacity, Power Generation and Investments for the global hydropower market as well as for key countries such as the US, Canada, Brazil, Russian Federation, Norway, China, Japan, Venezuela, Turkey, Switzerland, Mexico and India.

• Market Value and Competitive Analysis of various hydropower project owners by country.

• Analysis of Global Hydro Turbine Manufacturers Market a well as providing Key Drivers and Challenges for the development of hydropower market.

• Major hydropower policies supporting the development of the market are also covered for the key countries.

Browse All: Power Market Research Reports 

Reasons to Buy

• The report will enhance your decision making capability. It will allow you to:

• Facilitate decision-making based on strong historic and forecast data for thin-film market.

• Develop strategies based on the various market developments in the thin-film industry.

• Position yourself to gain the maximum advantage of the thin-film industry’s growth potential.

• Identify key partners and business development avenues based on the understanding of the market movements of the major competitors in the thin-film market.

• Respond to your competitors’ business structure, strategy and prospects.

Type 1 Diabetes Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Published: October 2011
No. of Pages: 102
Price: $ 3500


Industry analysis specialist, GlobalData, has released its new report, “Type 1 Diabetes Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information on the global type 1 diabetes therapeutics market, and provides analysis of a number of key areas. The report identifies the key trends shaping and driving the global type 1 diabetes therapeutics market and provides insights into the current competitive landscape and emerging companies expected to significantly alter the market positioning of current market leaders. Most importantly, the report provides valuable insights into the pipeline products within the global type 1 diabetes sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Browse All: Pharmaceuticals Market Research Reports

Scope
• The report provides information on the key drivers and challenges of the type 1 diabetes therapeutics market. Its scope includes:
• Annualized seven key markets (the US, France, Germany, Italy, Spain, the UK and Japan) type 1 diabetes therapeutics market revenue data for 2005–2010, and 2011–2018.
• Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidate’s fall under the therapy classes such as immunomodulator, anti-CD3 antibody, oral Insulin analogue, GLP-1 receptor agonist, interleukin-1 inhibitor, ultra-long acting insulin analogue, ultra-fast-acting insulin analogue, Insulin analogue and ultra rapid-acting insulin analogue.
• Analysis of the current and future competition in the seven key countries of the type 1 diabetes therapeutics market. Biodel Inc., Eli Lilly and Company, Evotec, Diamyd Medical AB, Diasome Pharmaceutical Inc., Generex Biotechnology Corporation, GlaxoSmithKline, Halozyme Therapeutics Inc., MacroGenics, MannKind Corporation and Novo Nordisk, they are key market players, is covered in this section.
• Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
• Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the type 1 diabetes therapeutics market.
• Analysis of key recent licensing and partnership agreements in type 1 diabetes therapeutics market.

Reasons to Buy
• The report will enhance your decision making capability. It will allow you to:
• Develop and design in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the global type 1 diabetes therapeutics market.
• Increase revenue through an understanding of the key trends, innovative products and technologies, market segments and companies likely to affect the global type 1 diabetes therapeutics market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Organize sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
• What’s the next big thing in the global type 1 diabetes therapeutics market landscape? – Identify, understand and capitalize.

Oil Refining Industry in South East Asia, 2011 - Market Analysis, Competitive Scenario and Capacity Forecasts to 2015

Published: October 2011
No. of Pages: 65
Price: $ 3500

Oil Refining Industry in South East Asia, 2011 - Market Analysis, Competitive Scenario and Capacity Forecasts to 2015, is the latest report from GlobalData, the industry analysis specialists, that analyzes the oil refining industry in South East Asia. The report provides information about the South East Asia’s oil refinery market until 2015. The report gives information on key oil refinery projects and key companies in all the seven countries in the region.. The report also provides key trends and issues in the refining industry. The report is built using the data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Asia Pacific region includes some of the world’s fastest growing economies, such as China, India, and South Korea. With rapid growth in the economies of these countries, the demand for petroleum products in these countries - and in Asia Pacific by large - is also increasing at a rapid pace. In spite of huge oil refining capacities in countries such as China and India, these countries need to import petroleum products to meet their domestic demand.

Scope

• This report provides detailed analysis of South East Asia oil refining markets, key companies and the key trends and issues in the industry until 2015. The report primarily focuses on:

• Oil refining market in South East Asia

• Key companies in refining sector for each country

• Key refinery projects in each country

• Key issues and trends in refining sector in South East Asia

• Competitive landscape of the oil refining sector containing comparison between key companies and key refinery projects

Browse All: Power Market Research Reports

Reasons to Buy

• The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:

• Understand the expected change in dynamics of the global refining market by understanding the new emerging markets in South East Asia

• Develop business strategies with the help of specific insights about the refining market in this developing region.

• Identify opportunities and challenges in the South East Asian refining market

• Understand the market positioning of the major refining countries and companies in South East Asia

 

OLED Displays and Lighting Market to 2020 - Technological Innovations Lead to Cost Efficient Products and New Aesthetics

Published: October 2011
No. of Pages: 100
Price: $ 3500

GBI Research, a leading business intelligence provider, has released its latest research, “OLED Displays and Lighting Market to 2020 - Technological Innovations Lead to Cost Efficient Products and New Aesthetics”. The report gives an in-depth analysis of the global Organic Light Emitting Diodes (OLED) market for displays and lighting, covering four major regions – North America (USA and Canada), Europe, Asia–Pacific. The report covers market revenue forecasts for the OLED market (Displays and Lighting) from 2005-2020 It also provides market revenues breakdown for displays by application types; Cell Phones, Televisions, IT Monitors and Others and technology type; Passive Matrix Organic Light Emitting Diode (PMOLED) Displays and Active Matrix Organic Light Emitting Diode (AMOLED) Display.

For OLED lighting segment, the report provides covers market revenue forecasts from 2010-2020. It also provides market revenues breakdown for displays by application types; Specialty Lighting, Architecture Lighting, Back Lighting, Signage and General Illumination. The research analyzes market dynamics, challenges and trends, supply chain analysis, potential applications, opportunities, regulatory framework, major projects undertaken for technology developments in the three most significant regions, North America, Europe and Asia-Pacific.. This report is built using data and information sourced through primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Browse All: Power Market Research Reports

Scope

• The Global OLED market revenue for Displays and Lighting with geographic analysis covering three regions – North America (USA and Canada), Europe, Asia – Pacific.

• The OLED market for Displays in four application types - Cell Phones, Televisions, IT Monitors and Others

• The OLED market for Displays by technology types - Passive Matrix Organic Light Emitting Diode (PMOLED) Displays and Active Matrix Organic Light Emitting Diode (AMOLED) Display.

• The OLED market for Lighting in four application types - Specialty Lighting, Architecture Lighting, Back Lighting, Signage and General Illumination

• Technology Overview of Displays and Lighting

• The Regulatory Framework, Developmental Activities, Major Technology Projects, Technology Roadmap, Supply Chain and Competitive Analysis

• Insights into the major trends, drivers and challenges in the overall industry.

• Market revenue from 2005 to 2010, with forecasts to 2020.

• Business overview, SWOT Analysis and review of the operational metrics of key companies in the OLED Lighting Industry. These include Osram, GE Lighting, Philips, and Lumiotec.

Reasons to buy

• Identify key markets and investment opportunities in the OLED displays and lighting market.

• Make decisions based on strong historical and forecast data and detailed growth opportunities analysis.

• Understand and respond to the market dynamics in North America (The US and Canada), Europe, Asia–Pacific regions.

• Position yourself to take maximum advantage of the market’s growth potential.

• Identify the risks associated with the market and transform them into opportunities for future growth.

• Identify the scope of emerging technologies and applications in the market.

Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value

Published: October3, 2011
No. of Pages: 169
Price: $ 3500


GBI Research, the leading business intelligence provider, has released its latest research “Metabolic Disorders Therapeutics Market to 2017 – Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value”, which provides insights into metabolic disease therapeutics marled until 2017. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. The report provides an in-depth analysis of the major metabolic diseases including Diabetes, Obesity and Dyslipidemia. The report also provides the share of generics in global metabolic diseases as well as in each indication market. It also provides the treatment algorithm flow for each three indications. The report examines the global metabolic diseases treatment usage patterns. In addition, the geographical distribution of metabolic diseases and market across the US, the top five countries of Europe and in Japan are provided in the report. The report also includes insights into the metabolic diseases R&D product pipeline and explores the competitive landscape including major players in metabolic disorder therapeutics market. Finally, the report also includes analysis on Mergers and Acquisitions (M&As) and licensing agreements that took place in metabolic disorder therapeutics market.

Browse All: Pharmaceuticals Market Research

Scope
• The report analyzes treatment usage patterns, market characterization, pipeline analysis, competitive landscape and key M&A trends in the global metabolic disorder therapeutics market for the three indications that includes Diabetes, Obesity and Dyslipidemia.
• The report covers:
• Data and analysis on the metabolic disorder therapeutics market in the leading geographies of the world – the US, the UK, Germany, France, Italy, Spain, and Japan.
• Annualized market data for the metabolic disorder therapeutics market from 2002 to 2010, with forecasts to 2017 for three indications which includes diabetes, obesity and dyslipidemia
• Market data on the geographical landscape and therapeutic landscape, including market size, market share, annual cost of therapy, sales volume and treatment usage patterns such as disease population, treatment seeking population, diagnosis population and prescription population.
• Share of the generics in global metabolic disorder therapeutics market and for the market of each indication that is covered in the report.
• Key drivers and restraints that have had a significant impact on the market.
• The competitive landscape of the global metabolic disorder market including top companies benchmarking. The key companies studied in this report are Pfizer Inc., Novo Nordisk, Sanofi, Takeda, Eli Lilly, GlaxoSmithKline and Merck & Co. Inc.
• Key M&A activities and Licensing Agreements that took place in 2009 and 2011 in the metabolic disorder therapeutics market.

Reasons to Buy
• The report will assist business development and marketing executives to strategize their product launches, by allowing them to:
• Align your product portfolio to the markets with high growth potential.
• Build effective strategies to launch their pipeline products by identifying potential geographies.
• Exploit in-licensing and out-licensing opportunities by identifying products that might fill their portfolio gaps.
• Develop key strategic initiatives by studying the key strategies of top competitors.
• Device a more tailored country strategy through the understanding of key drivers and barriers and market potential of each indication.
• Develop market-entry and market expansion strategies by identifying the geographic markets poised for strong growth.
• Reinforce R&D pipelines by identifying new target mechanisms which can produce first-in-class molecules which are safer and more efficacious.

Clinical Trial Recruitment in Dermatology - Most Trials Focus on Atopic Dermatitis While Acne Vulgaris Has Highest Patie

Published: October 3, 2011
No. of Pages: 89
Price: $ 3500

GBI Research’s report ‘Clinical Trial Recruitment in Dermatology - Most Trials Focus on Atopic Dermatitis While Acne Vulgaris Has Highest Patient Numbers’ provides an in-depth analysis of the current patient recruitment scenario for major indications under dermatology. The report analyzes a number of clinical trials conducted for major indications. It provides information about the total number of clinical trials conducted by phase, geography, major sponsors and clinical trials per year. An analysis of the total number of patients recruited for major indications is given. The report analyzes total number of patients recruited by phase of clinical trial, geography and major sponsors. An analysis of the average number of patients recruited per trial per year for various indications is also given. Clinical trials are being conducted on dermatological diseases in order to find better treatment options. There has been an increase in the number of clinical trials conducted due to a rise in the prevalence of dermatology disorders. A clinical trial is one of the most critical parts of the drug development process.

Scope

• The report analyzes dermatology clinical trial recruitment trends for pharmaceutical companies for various dermatological trials. Its scope includes:

• Insight on clinical trials conducted for major indications of dermatological diseases such as acne vulgaris, atopic dermatitis, candidiasis, herpes zoster and alopecia between 2000 and 2010.

• The status of patient recruitment by geography, sponsor company, year and stage of development.

• Analysis of the average number of patients recruited per trial for major indications per year.

• Analysis of the average number of patients recruited per trial for major indications by stage of development.

• The prevalence population in India, China and Brazil for all major indications from 2010 to 2017.

Browse All: Pharmaceuticals Market Research Reports

Reasons to Buy

• The report will enhance your decision making capability. It will allow you to:

• Identify and understand the status of clinical trials conducted for major dermatology indications from 2000 to 2010.

• Build understanding of patient recruitment status by geography, sponsor company, year and stage of development.

• Identify the prevalence population for major indications until 2017.

• Identify the average number of patients recruited by stage of development and across years for all major indications.

• Identify the indication for which the most trials are conducted and most patients are recruited.

Contraceptives Market to 2017 - Hormonal Contraceptives and Strong Pipeline to Drive the Growth in Future

Published: October 2011
No. of Pages: 80
Price: $ 3500


GBI Research, the leading business intelligence provider, has released its latest research, “Contraceptives Market to 2017” which provides insights into global contraceptives market and market forecast until 2017. Report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. The report provides an in-depth analysis of the contraceptives used. The report provides an in-depth analysis of the oral contraceptives, topical contraceptive, injectable contraceptive, intrauterine devices, condoms and vaginal rings. The report examines the oral, topical and injectable contraceptives treatment usage patterns. The report also includes insights into the contraceptives R&D product pipeline and explores the competitive landscape including major players in contraceptives market. Finally, the report also includes analysis on Mergers and Acquisitions (M&As) and licensing agreements that took place in contraceptives market.

Browse All: Pharmaceuticals Market 


Scope
• The report analyzes market characterization, pipeline analysis and key M&A trends in the oral contraceptives, topical contraceptives, injectable contraceptives, condoms, intrauterine devices and vaginal rings in the contraceptives market.
• The scope of this report includes:
• Data and analysis on the contraceptives market in the leading geographies of the world – the US, the UK, Germany, France, Italy, Spain, and Japan.
• Annualized market data for the oral contraceptives, topical contraceptives, injectable contraceptives, condoms, intrauterine devices and vaginal rings in the contraceptives market from 2002 to 2010, with forecasts to 2017.
• Market data on the therapeutic landscape which covers oral, topical, injectable contraceptive and includes market revenues, treatment usage patterns and annual cost of therapy.
• Key drivers and restraints that have had a significant impact on the market
• The competitive landscape of the contraceptives market which includes companies such as Bayer, Johnson & Johnson, Reckitt Benckiser, Church & Dwight and Merck.
• Key M&A activities and Licensing Agreements that took place from 2005 to 2011 in the contraceptives market.

Reasons to Buy
• The report will enhance your decision making capability. It will allow you to
• Align your product portfolio to the markets with high growth potential.
• Develop market-entry and market expansion strategies by identifying the potential region and therapeutic segments poised for strong growth.
• Device a more tailored country strategy through the understanding of key drivers and barriers of the contraceptives market.
• Develop key strategic initiatives by understanding the key focus areas of leading companies.
• Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.

Non - Small Cell Lung Cancer (NSCLC)Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Published: October 2011
Price: $3500

Report Summary

GlobalData, the industry analysis specialist, has released its new report, “Non - Small Cell Lung Cancer (NSCLC)Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global Non - Small Cell Lung Cancer (NSCLC)Therapeutics market. The report identifies the key trends shaping and driving the global Non - Small Cell Lung Cancer (NSCLC)Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Non - Small Cell Lung Cancer (NSCLC)Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts

Scope

• The report provides information on the key drivers and challenges of the Non - Small Cell Lung Cancer (NSCLC)Therapeutics market. Its scope includes:
• Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Non - Small Cell Lung Cancer (NSCLC)Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2017.
• Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
• Analysis of the current and future competition in the seven key countries Non - Small Cell Lung Cancer (NSCLC)Therapeutics market.
• Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
• Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Non - Small Cell Lung Cancer (NSCLC)Therapeutics market.
• Analysis of key recent licensing and partnership agreements in Non - Small Cell Lung Cancer (NSCLC)Therapeutics market

Reasons to Buy

• The report will enhance your decision making capability. It will allow you to:
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the global Non - Small Cell Lung Cancer Therapeutics market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Non - Small Cell Lung Cancer (NSCLC)Therapeutics market in future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
• What’s the next big thing in the global Non - Small Cell Lung Cancer (NSCLC)Therapeutics market landscape? – Identify, understand and capitalize.

Atopic Dermatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Published: October 2011
No. of Pages: 68
Price: $ 3500



GlobalData, the industry analysis specialist, has released its new report, “Atopic Dermatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global Atopic Dermatitis Therapeutics market. The report identifies the key trends shaping and driving the global Atopic Dermatitis Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Atopic Dermatitis Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Browse All: Pharmaceuticals Market Research

Scope
The report provides information on the key drivers and challenges of the Atopic Dermatitis Therapeutics market. Its scope includes -
• Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Atopic Dermatitis Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2017.
• Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
• Analysis of the current and future competition in the seven key countries Atopic Dermatitis Therapeutics market.
• Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
• Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Atopic Dermatitis Therapeutics market.
• Analysis of key recent licensing and partnership agreements in Atopic Dermatitis Therapeutics market

Reasons to buy
The report will enhance your decision making capability. It will allow you to -
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the global Atopic Dermatitis Therapeutics market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Atopic Dermatitis Therapeutics market in future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
• What’s the next big thing in the global Atopic Dermatitis Therapeutics market landscape? - Identify, understand and capitalize.

Eagle Ford Shale in the US, 2011 - Oil Shale Market Analysis and Forecasts to 2020

Published: October 2011
No. of Pages: 40
Price: $ 1500

GlobalData’s new report ‘Eagle Ford Shale in the US, 2011 - Oil Shale Market Analysis and Forecasts to 2020’ analyzes the recent activities in the Eagle Ford shale play in the US. The report details the drilling activity in the play by analyzing the permits issued in Eagle Ford shale by period, county and also by major operators. It also provides the well costs and acreage costs. The report gives the major players in the shale play in terms of acreage and production. It also details the expected production from the shale play by 2020. The report details the major recent M&A activities in the play and provides the future plans of major companies involved in the Eagle Ford shale play.

Browse All: Power Market Research Reports

The Eagle Ford shale play is encountering increased activity and interest from oil and gas companies. Increased drilling activities, acreages and production in the shale play are apt indicators of this development. As of June 2011, the Texas Rail Road Commission (RRC) had issued a total of 1,241 drilling permits in the Eagle Ford shale play during the period January to June 2011. The figure for 2010 was 1,010. Additionally, substantial investments are to be seen in the shale play. About $4.6 billion investments in capital expenditure are expected in the near future from major companies.

Scope

The report analyzes the activities in the US Eagle Ford shale. The scope of the report includes -

• Major companies in the Eagle Ford shale by acreage and by production.

• Eagle Ford shale production trends and expected production during 2010-2020.

• Cost per well and acreage cost for major players in the shale play.

• Eagle Ford shale drilling details by period, county and operators.

• Major merger and acquisition in the Eagle Ford shale play during 2010-2011.

• Analysis of operations of major companies in the play such as EOG Resources, Petrohawk and others.

Reasons to buy

The report will enhance your decision making capability. It will allow you to -

• Understand the changing dynamics of the oil and gas industry in the US by understanding the role that shale plays in the energy industry of the country.

• Develop business strategies with the help of specific insights about this shale play.

• Understand trends and activities in Eagle Ford shale play.

• Understand the market positioning of the major players in this shale play.

• Increase future revenue and profitability with the help of insights about future opportunities and critical success factors in the shale plays.

 

Luxembourg Power Market Outlook to 2030 - Business Propensity Indicator ( BPI ) Market Trends Regulation and Competitive Landscape

Published: October 2011
No. of Pages: 59
Price: $ 1500


This report Luxembourg Power Market Outlook to 2030 - Business Propensity Indicator ( BPI ) Market Trends Regulation and Competitive Landscape includes a detailed analysis of the current investment climate in the country’s power sector and over the next decade across 6 broad parameters. Each parameter has a weight assigned, and a weighted average score is calculated to obtain the final country ranking in that region. The study also maps the relative ranking of the key countries in the region according to the current investment opportunities in the country and that by 2020.

This report also examines the country’s power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed analysis of the market’s regulatory structure, supply and demand balance, import and export trends, competitive landscape and power projects at various stages of the supply chain is provided.

Browse All: Energy Market Research Reports

Scope
• Analysis of the current investment climate in the country’s power sector across six parameters and over the next decade
• Relative ranking of the key country’s in the region according to the current investment opportunities in the country and that by 2020.
• Statistics for installed capacity, power generation and consumption from 2000 to 2010, forecast forward 19 years to 2030
• Break-up by technology, including thermal, hydro, renewable and nuclear
• Data on key current and upcoming projects
• Information on grid interconnectivity, distribution losses and power exports and imports
• Policy and regulatory framework governing the Luxembourg Power Market
• Detailed analysis of top market participant, including market share analysis and SWOT analysis
• Data sourced from proprietary databases and primary interviews with key participants across the value chain

Reasons to buy
• Identify opportunities and plan strategies by having a strong understanding of the investment opportunities in the country’s power sector
• Identification of key factors driving investment opportunities in the country’s power sector
• Facilitate decision-making based on strong historic and forecast data
• Develop strategies based on the latest regulatory events
• Position yourself to gain the maximum advantage of the industry’s growth potential
• Identify key partners and business development avenues
• Identify key strengths and weaknesses of important market participants
• Respond to your competitors’ business structure, strategy and prospects

Rheumatoid Arthritis Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Published: October 2011
Price: $ 3500


GlobalData, the industry analysis specialist, has released its new report, “Rheumatoid Arthritis Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global rheumatoid arthritis therapeutics market. The report identifies the key trends shaping and driving the global rheumatoid arthritis therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global rheumatoid arthritis therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Browse All: Pharmaceuticals Market Research

Scope
The report provides information on the key drivers and challenges of the rheumatoid arthritis therapeutics market. Its scope includes -
• Annualized revenue data from seven key markets (the US, France, Germany, Italy, Spain, the UK and Japan) in the rheumatoid arthritis therapeutics market from 2005 to 2010, and forecasts for eight years to 2018.
• Pipeline analysis data, providing analysis split across the different phases, mechanisms of action being developed and emerging trends in the pipeline. Pipeline candidates fall under a variety of major therapeutic classes such as p38 kinase inhibitors, Janus Kinase Inhibitors (JAK), tyrosine kinase inhibitors, dihydrofolate reductase inhibitors, cyclooxygenase (COX) inhibitors, Dihydroorotate dehydrogenase (DHODH) inhibitors, interleukin inhibitors, tumor necrosis factor (TNF) inhibitors, chemotaxis inhibitors, Vascular Adhesion Protein-1 (VAP 1) inhibitors, granulocyte macrophage colony stimulating factor (GM-CSF) inhibitors, Toll-like receptors (TLRs) and anti-CD 20 monoclonal antibodies.
• Analysis of the current and future competition in the global rheumatoid arthritis therapeutics market. The key market players covered are AstraZeneca PLC, Eli Lilly and Company Eisai Co., Ltd GlaxoSmithKline plc, Pfizer Inc, Sanofi, Merck & Co., Inc., Novartis AG and Regeneron Pharmaceuticals, Inc.
• Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
• Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the rheumatoid arthritis therapeutics market.
• Analysis of key recent licensing and partnership agreements in the rheumatoid arthritis therapeutics market.

Reasons to buy
The report will enhance your decision-making capability. It will allow you to -
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipelines.
• Develop business strategies by understanding the trends shaping and driving the global rheumatoid arthritis therapeutics market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global rheumatoid arthritis therapeutics market in future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidations, investments and strategic partnerships.
• What’s the next big thing in the global rheumatoid arthritis therapeutics market landscape? – Identify, understand and capitalize.